Nikolce Gjorevski - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Nikolce Gjorevski

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

The Journal of Clinical Investigation|February 5, 2020

Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in miceSimone Ragusa, Borja Prat-Luri, Alejandra González-Loyola, et al.

Biorxiv : the Preprint Server for Biology|August 20, 2025

Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcomeFabien Bertillot, Solène Hervé, Nelly Drobjazko, et al.

Elife|August 11, 2021

Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodiesS Jordan Kerns, Chaitra Belgur, Debora Petropolis, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

The Journal of Clinical Investigation|February 5, 2020

Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in miceSimone Ragusa, Borja Prat-Luri, Alejandra González-Loyola, et al.

Biorxiv : the Preprint Server for Biology|August 20, 2025

Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcomeFabien Bertillot, Solène Hervé, Nelly Drobjazko, et al.

Elife|August 11, 2021

Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodiesS Jordan Kerns, Chaitra Belgur, Debora Petropolis, et al.

Pageof 3